Anteis SA is a Swiss company that is one of the worldwide actors specialized in the development, manufacturing and distribution of innovative injectable medical devices based on biopolymer transformation. It provides revolutionary solutions to challenges in the fields of aesthetic dermatology, ophthalmology and orthopaedics. Its innovations include the development of a range of biopolymer-based injectable gels and the launch, in 2009-2010, of an easy-to-use injection system for gel-based products that is set to become an industry standard. Swiss manufacturing standards guarantee world-class products and the science-based approach of its small team of entrepreneurial owner-managers ensures a strong focus on rigorous testing and analysis.
Fongit Seed Invest
January 23, 2012 by
Fongit Seed Invest (FSI) is a seed investment fund that primarily invests in ventures having a potential market above CHF 100 million, and with projected revenue higher than CHF 5 million per year, within 5 years. FSI acts either as a lead investor or co-investors and has strong connections with venture capitalists, business angels, and institutional funds (PPP). FSI is known throughout the network of universities, Venture Capitalists, Business Angels and specialised organisations (private & public). Fongit is the major shareholder and primary partner and FSI’s funding members are: the CIA Pension Fund of the Geneva Canton (Caisse de Prévoyance CIA) and Rolex Pension Fund (Caisse de Pensions Paritaire Rolex) are other contributors.
SalsaDev
December 28, 2011 by
salsaDev SA is a software company specialized in advanced, intelligent technologies capable to understand complex, unstructured sources of text. Designed for the enterprise market, the software can automatically organize and find documents, saving considerable time and efforts for organizations and its employees.
The main features of salsaDev software are designed specifically to ease the strain on information workers by providing Semantic Search, Automatic Categorization and Conceptually Related Content. Traditional systems use full text indexing and work with structured information such as tags, categories and metadata. These approaches, when faced with the unstructured raw data typically seen in enterprise scenarios, rapidly become inapplicable.
Medicontur
December 27, 2011 by
Medicontur develops, manufactures and promotes intraocular implants which meet patients and surgeons’ expectations. Twenty years of continuous growth, coupled with an exemplary proven safety record, has meant that distributors in many countries worldwide now rely on Medicontur’s commitment to quality.
Medicontur offers a full range of Aspheric Hydrophilic/ Aspheric Hydrophobic IOL’s for MICS and MINI incisions, also available with a Natural yellow filter as well as Toric IOL’s, CTR’s and disposable injection kits.
BioXpress Therapeutics
November 15, 2011 by
Located in Geneva, Switzerland, BioXpress Therapeutics SA (BXT) is a premier provider of high-quality biosimilar monoclonal antibody (MAbs) for unmet need indications. As a class, MAbs are forecasted to grow at a CAGR approaching 10% over the next five years, driven largely by positive results in the clinic. Cancers and immune-related inflammatory diseases will continue to be leading markets for MAbs during the next five-years.
BXT is focused on developing the highest quality product under strict European Medicines Agency (EMA) guidelines. We bring together the world’s top biologic development, manufacturing and regulatory experts dedicated to assuring the quality of our drugs. BXT believes all patients should have access to safe and high-quality biologic therapeutics at affordable costs.